Skip to content

Effects of Fatty and Lean Fish Intake on Cardiovascular Risk Factors in Subjects With Coronary Heart Disease

Effects of Fatty and Lean Fish Intake on Cardiovascular Risk Factors in Subjects With Coronary Heart Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00720655
Enrollment
33
Registered
2008-07-23
Start date
2005-08-31
Completion date
Unknown
Last updated
2014-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmia, Blood Pressure, Inflammation

Keywords

coronary heart disease

Brief summary

The aim of the study is to examine the effects of fatty fish and white (lean) fish on cardiovascular disease risk factor levels in subjects with established coronary heart disease using multiple medications. The main end points are blood pressure, serum lipids, inflammatory markers, arrhythmias and gene expression in peripheral mononuclear cells. The study design was a controlled, parallel study lasting 8 weeks with three diet groups: fatty fish, white fish and control group (lean pork, beef or chicken).

Interventions

OTHERDietary intervention

Fatty fish at least 4 meals per week.

Sponsors

Kuopio University Hospital
CollaboratorOTHER
University of Eastern Finland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 70 Years
Healthy volunteers
No

Inclusion criteria

* myocardial infarction or unstable ischemic attack * use of beta blockers * normal sinus rhythm * fasting serum triglyceride less or equal to 3.5 mmol/l * fasting serum cholesterol less or equal to 8 mmol/l * BMI 18.5-30 kg/m2 * fasting plasma glucose less or equal to 7 mmol/l

Exclusion criteria

* diabetes * use of other antiarrhythmic medications than beta blockers * atrial fibrillation * use of psychotropic medications * abnormal liver, thyroid or kidney function * inflammatory bowel disease * excessive use of alcohol * use of fish oil supplements or high habitual intake of fish

Design outcomes

Primary

MeasureTime frame
gene expression in peripheral mononuclear blood cells, risk of arrhythmias, serum lipids and blood pressure8 week

Secondary

MeasureTime frame
inflammatory markers8 week

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 3, 2026